vTv Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013
Net Income	-20.25	-19.16	-12.99	-8.5	-17.91	-8.65	-16.14	-16.35	-27.5	-36.1	Upgrade
Depreciation & Amortization	0.09	0.09	0.09	0.09	0.04	0.22	0.2	0.27	0.5	0.86	Upgrade
Share-Based Compensation	1.58	1.27	2.36	1.01	1.52	2.68	3.65	2.64	0.86	0	Upgrade
Other Operating Activities	-0.5	1.78	-8.77	-10.6	-11.53	-21.84	-32.26	-34.76	-10.81	4.46	Upgrade
Operating Cash Flow	-19.08	-16.02	-19.31	-18	-23.02	-26.86	-44.56	-48.21	-36.95	-30.78	Upgrade
Capital Expenditures	0	-0.02	0	0	0.24	0.01	-0.03	-0.08	-0.08	0.3	Upgrade
Change in Investments	4.4	0	0	0	0	0	0	0	0	0	Upgrade
Other Investing Activities	-	-	-	-	-	-	-	-	-	-0.14	Upgrade
Investing Cash Flow	4.4	-0.02	0	0	0.24	0.01	-0.03	-0.08	-0.08	0.16	Upgrade
Share Issuance / Repurchase	12.03	14.79	26.8	24.43	32.94	21.5	0	0	105.77	0	Upgrade
Debt Issued / Paid	-0.03	-0.03	0.17	-4.96	-10.07	-4.89	7.5	11.79	19.2	33.41	Upgrade
Other Financing Activities	-	-	-	-	-	-	-	-	-1.33	-2.5	Upgrade
Financing Cash Flow	12	14.75	26.98	19.47	22.87	16.61	7.5	11.79	123.64	30.91	Upgrade
Net Cash Flow	-2.68	-1.29	7.67	1.47	0.09	-10.24	-37.09	-36.5	86.62	0.3	Upgrade
Free Cash Flow	-19.08	-16.04	-19.31	-18	-22.78	-26.85	-44.59	-48.29	-37.03	-30.48	Upgrade
Free Cash Flow Margin	-	-795.00%	-482.10%	-280.64%	-824.02%	-215.93%	-15321.31%	-7617.03%	-7133.91%	-1967.59%	Upgrade
Free Cash Flow Per Share	-7.30	-6.14	-8.58	-9.74	-15.21	-26.36	-54.35	-58.87	-45.13	-	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).